SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Stateside's Canadian Microcap Board
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: statesidereport who wrote (1597)4/15/2016 7:31:04 AM
From: Dave@SI  Read Replies (1) of 1728
 
TLT NR today re paper published about the transferrin benefit to TLD-1433.

You've got to admire their futuristic writing style:

"Theralase is focused on successfully completing a Phase Ib..."

Which might be edited by the less sanguine as:

"Theralase is focused on successfully starting a Phase Ib ..."

As I remember it the transferrin-enhancement does not get used in the pending trial?
A: Yes/No/Your guess is as good as mine - Delete as appropriate.

BTW, BCT are at AACR on Monday, anyone feel like buying in advance of the rush? Thought not.

I am still long here (both), just a bit bored and cynical.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News